Trials / Active Not Recruiting
Active Not RecruitingNCT06710470
A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring
Deucravacitinib Pregnancy Study: A Retrospective Observational Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 833 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- Female
- Age
- 15 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
This observational study aims to assess pregnancy and infant outcomes among pregnant women with psoriasis who have been exposed to deucravacitinib treatment in the USA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Deucravacitinib | As per product label |
| DRUG | Systemic psoriasis medications | As per product label |
| OTHER | No systemic medications | Participants not exposed to any systemic medications |
Timeline
- Start date
- 2024-08-02
- Primary completion
- 2027-01-31
- Completion
- 2029-02-28
- First posted
- 2024-11-29
- Last updated
- 2024-11-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06710470. Inclusion in this directory is not an endorsement.